Mileutis raises $20 million to reduce antibiotic use in cows


Mileutis Ltd., a company based in Ness Ziona, Israel raised $20 million to develop a drug that is designed to treat mastitis in cows. The private venture capital company, U.S.-based NovaQuest Capital Management LLC, which specializes in health and life sciences and oversees some $2 billion in investments, invested in the Israeli company. NovaQuest’s investment is the first of its kind in the health and life sciences sector and the first for Mileutis. Mileutis was represented by Adv. Gary Copelovitz, Head of our International Department. To read more please click here